Clinical Trials Logo

Filter by:
NCT ID: NCT02198040 Completed - Clinical trials for Patients With Hemophilia

Physiotherapy in the Haemophilic Arthropathy of the Elbow.

ELBOW
Start date: January 2012
Phase: N/A
Study type: Interventional

The aim of this study is to assess the effectiveness of two treatments of Physiotherapy: one with joint traction, passive muscles stretching and Proprioceptive Neuromuscular Facilitation (PNF), and the other with education sessions and home exercises, for the improvement of the ROM, biceps strength, perimeter of arm and the perception of pain in PwH and arthropathy of the elbow.

NCT ID: NCT02198014 Completed - Clinical trials for Patients With Haemophilia

Manual Therapy in Haemophilic Arthropathy of the Knee

ARTHROPA
Start date: January 2012
Phase: N/A
Study type: Interventional

This study aims to assess the effectiveness of two Physiotherapy treatments: one with manual therapy using joint traction, passive muscle stretching, and isometric exercise, active resisted and proprioception exercises; and other treatment with educational sessions and home exercises to improve the ROM, muscle strength and proprioception in patients with haemophilia and arthropathy of the knee.

NCT ID: NCT02197247 Completed - Clinical trials for Non Small Cell Lung Cancer

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Start date: December 4, 2014
Phase: Phase 1
Study type: Interventional

This is a Phase I, open-label, 2-part study in patients with a confirmed diagnosis of epidermal growth factor receptor (EGFR) mutation positive (EGFRm+) non-small cell lung cancer (NSCLC), who have progressed following prior therapy with an approved EGFR tyrosine kinase inhibitor (TKI) agent. Part A will assess the effect of rifampicin on the pharmacokinetic (PK) parameters of AZD9291 and metabolites AZ5104 and AZ7550 following multiple oral dosing of both rifampicin and AZD9291 in a fasted state. Part B will allow patients further access to AZD9291 after the PK phase (Part A) and will provide for additional safety data collection. All patients who complete Part A will be able to enter part B, and continue to receive AZD9291 80 mg once daily until: disease progression; they are no longer deriving clinical benefit; or any other reason.

NCT ID: NCT02196948 Completed - Clinical trials for Supraspinatus Tendinopathy

Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy

Start date: July 2014
Phase: N/A
Study type: Interventional

Therapeutic management of supraspinatus tendinopathy is conflicting. There is evidence that eccentric exercise protocols can be effective for this condition. The inclusion of other therapeutic modalities could help to the management of these patients. A new therapeutic approach, called Electrolysis Percutaneous Therapeutic (EPTE) has been clinically developed. The objective of this randomized clinical trial is to determine the effectiveness of the inclusion of EPTE into a eccentric exercise protocol for the management of patients with unilateral supraspinatus tendinopathy

NCT ID: NCT02196064 Completed - Clinical trials for Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects

Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."

hEPAtic
Start date: May 2014
Phase: N/A
Study type: Observational

To evaluate the incidence of grade 3 or 4 transaminase elevations or grade 4 total bilirubin elevations (hepatic toxicity) during the first 48 weeks of antiretroviral therapy with the combination of rilpivirine (25mg), tenofovir (245mg) and emtricitabine (200mg), in a single-tablet regimen (Eviplera®) in human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected subjects.

NCT ID: NCT02195882 Completed - Shoulder Pain Clinical Trials

Effect of an Exercise Program of the Scapular Muscle Stabilizers in Amateur Kayakers Shoulder Pain

Start date: May 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a specific strengthening program for the stabilizing scapular muscle can reduce shoulder pain of amateur kayaker.

NCT ID: NCT02195726 Completed - Acute Kidney Injury Clinical Trials

Efficacy of RIPC to Reduce AKI for Patients Undergoing PCI

EUROCRIPS
Start date: January 2013
Phase: Phase 4
Study type: Interventional

The purpose of the present study is to determine if remote ischemic preconditioning reduces incidence of acute kidney injury in patients with reduced kidney function undergoing Percutaneous Coronary Intervention.

NCT ID: NCT02195648 Completed - Clinical trials for Tension-Type Headache

Sub-occipital Muscle Inhibition in Tension Type Headache

TTH
Start date: February 2015
Phase: N/A
Study type: Interventional

The main objective of this study is to determine the effects caused in neck movement, neck pain, headache in patients with tension type headache and cervicogenic headache after application of sub-occipital muscle inhibition technique associated with interferential electrotherapy.

NCT ID: NCT02195609 Completed - Menopause Clinical Trials

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

OMEGASI
Start date: March 2014
Phase: Phase 4
Study type: Interventional

This study is aiming to evaluate changes in vasomotor symptoms in postmenopausal women treated for 4 months with Omega-3 vs Soy Isoflavones.

NCT ID: NCT02194985 Completed - Fabry Disease Clinical Trials

Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease

Start date: March 14, 2015
Phase: Phase 3
Study type: Interventional

This is an open-label extension study intended to provide continued treatment with migalastat hydrochloride (HCl) for participants with Fabry disease who completed treatment of a previous migalastat HCl study. The study assessed the long-term safety and effectiveness of migalastat HCl.